CMSC Wants Control of MS Treatment to Stay With PrescribersCMSC Wants Control of MS Treatment to Stay With Prescribers

A new position statement from the Consortium of Multiple Sclerosis Centers concludes that prescribers, not insurers, should drive decisions about disease-modifying and symptomatic treatments. Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news